Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04076644 · ClinicalTrials.gov registry record · NA
Maintenance Transcranial Magnetic Stimulation in Major Depressive Disorder
A NA study of MDD, sponsored by University of Missouri-Columbia.
- Completed
- Registry status
- NA
- Development phase
- 11
- Enrollment target
- 1
- Study location
NCT04076644 is a NA study of MDD that has completed, run by University of Missouri-Columbia. The registered enrollment target is 11 participants, below the 207-participant average among 7 other MDD trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04076644, a NA study of MDD, has completed, sponsored by University of Missouri-Columbia.
- COMPLETED
- Registry status
- NA
- Development phase
- 11 participants
- Enrollment target
- 1
- Study location
Study Summary
This an open label study using a FDA-cleared TMS stimulation protocols which will be used to treat patients who have responded or remitted from depression using acute clinical TMS therapy at the University of Missouri-Columbia Neuromodulation Clinic. TMS therapy will be given to subjects at monthly intervals. Depression severity questionnaires will be given monthly to determine if the subjects original response to TMS can be maintained. Subjects will be tapered down from antidepressant medication prior to TMS maintenance treatment. Results will be analyzed to determine the effectiveness and feasibility of maintenance TMS therapies in a clinical setting.
Conditions Studied
Interventions
- DEVICE TMS treatment
Study Locations (1)
Missouri
- University of Missouri Neuromodulation Center - Columbia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11 participants |
| Start Date | 2019-09-01 |
| Est. Completion | 2021-09-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04076644
The ClinicalTrials.gov registry entry for NCT04076644 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 11 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 207-participant average among 7 other MDD trials with a reported enrollment target (95% lower). The listed sponsor is University of Missouri-Columbia, which has 291 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with MDD appearing as the primary indexed condition, and to 1 intervention - of which TMS treatment is the first listed.
NCT04076644 reports 1 study location spanning 1 distinct geographic area - top geographies include Missouri.
Frequently Asked Questions
What is clinical trial NCT04076644 about?
NCT04076644 is a clinical study titled "Maintenance Transcranial Magnetic Stimulation in Major Depressive Disorder". This an open label study using a FDA-cleared TMS stimulation protocols which will be used to treat patients who have responded or remitted from depression using acute clinical TMS therapy at the University of Missouri-Columbia Neuromodulation Clinic. TMS therapy will be given to subjects at monthly ...
What is the current status of trial NCT04076644?
This trial is currently completed. It is a NA study. The enrollment target is 11 participants. The study started on 2019-09-01. Estimated completion is 2021-09-01.
What conditions does trial NCT04076644 study?
This clinical trial studies the following conditions: MDD.
What interventions are being tested in trial NCT04076644?
The interventions under investigation include: TMS treatment (DEVICE).
Who is sponsoring clinical trial NCT04076644?
This trial is sponsored by University of Missouri-Columbia, which has 291 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04076644 being conducted?
This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for MDD
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Neural-Derived Plasma Exosomal MicroRNAs As Promising Novel Biomarkers for Suicidality and Treatment Outcome in Adolescents
RECRUITING · NA
-
Feasibility of Home-Based Intermittent 60Hz Light Therapy for Major Depressive Disorder (MDD)
RECRUITING · NA
-
Theta Burst Stimulation for Refractory Depression in Autism Spectrum Disorder
ACTIVE NOT RECRUITING · NA
-
Can Mental Health Apps Work in the Real World? A Feasibility Pilot Study.
COMPLETED · NA
-
Extended Reality Behavioral Activation: An Intervention for Major Depressive Disorder
COMPLETED · NA
-
Mechanism of Action of tACS for the Treatment of MDD
COMPLETED · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.